Nestle CEO discusses impact of weight loss drugs on food industry
The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new opportunities for food companies, Nestle CEO Mark Schneider told CNBC. Investors were initially concerned …